Medicus Pharma Ltd. (MDCX)
NCM · Healthcare · Drug Manufacturers - General
$0.34
+1.50%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$19.2M
Shares Outstanding
56.7M
Exchange
NCM
Currency
USD
About Medicus Pharma Ltd.
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.